Advertisement
Advertisement
NTLA
Intellia Therapeutics, Inc
12.31
USDSponsored
+0.45
+3.79%
Nov 04, 15:59 UTC -5
Closed
After-Market
12.31
0.00
-0.01%
Intellia Therapeutics, Inc (NTLA)
Intellia Therapeutics, Inc Financial Snapshot
| Market Cap | 1.72B |
| Beta | 1.83 |
| Earnings Per Share (EPS) | -3.36 |
| Price-to-Book (P/B) Ratio | 2.24 |
| Operating Margin | -672.16% |
| Total Debt/Equity (D/E) | 0.00% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -57.79% |
| Current Ratio | 6.65% |
| Free Cash Flow | -202.26M |
